A role for helical intermediates in amyloid formation by natively unfolded polypeptides?

Physical Biology

Volumn 6, Issue 1, 2009, Pages

  Abedini, Andisheh ^a   Raleigh, Daniel P ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; POLYPEPTIDE; PEPTIDE;

ARTICLE; BIOPHYSICS; IN VITRO STUDY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN INTERACTION; SPECTROSCOPY; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE;

AMYLOID; HUMANS; MODELS, MOLECULAR; PEPTIDES; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY;

EID: 62449226332     PISSN: 14783967     EISSN: 14783975     Source Type: Journal    
DOI: 10.1088/1478-3975/6/1/015005     Document Type: Article

References (53)

1. Chiti F and Dobson C M 2006 Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 75 333-6
2. Sipe J D 1994 Amyloidosis Crit. Rev. Clin. Lab. Sci. 31 325-54
3. Selkoe D 2003 Folding proteins in fatal ways Nature 426 900-4 (Pubitemid 38056883)
4. Vendruscolo M, MacPhee C E and Dobson C M 2003 Protein folding and misfolding: a paradigm of self-assembly and regulation in complex biological systems Phil. Trans. R. Soc. Ser. A 361 1205-22 (Pubitemid 37256226)
5. Tycko R 2004 Progress towards a molecular level understanding of amyloid fibrils Curr. Opin. Struct. Biol. 14 96-103 (Pubitemid 38249598)
6. Nelson R, Sawaya M R, Balbirnie M, Madsen A O, Riekel C, Grothe R and Eisenberg D 2005 Structure of the cross-beta spine of amyloid-like fibrils Nature 435 773-8 (Pubitemid 40839722)
7. Petkova A T, Ishii Y, Balbach J J, Antzutkin O N, Leapman R D, Delaglio F and Tycko R 2002 A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR Proc. Natl. Acad. Sci. USA 99 16742-7 (Pubitemid 36034043)
8. Luca S, Yau W-M, Leapman R and Tycko R 2007 Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR Biochemistry 46 13505-22 (Pubitemid 350209947)
9. Kirkitadze M D, Bitan G and Teplow D B 2002 Paradigm shifts in Alzheimer's disease and other neuro degenerative disorders: the emerging role of oligomeric assemblies J. Neurosci. Res. 69 567-77
10. Caughey B and Lansbury P T Jr 2003 Protofibrils, pores, fibrils and neurodegeneration: separating responsible protein aggregates from the innocent bystanders Annu. Rev. Neurosci. 26 267-98 (Pubitemid 37064935)
11. Kayed R, Head E, Thompson J L, McIntire T M, Milton S C, Cotman C W and Glable C G 2003 Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 486-9 (Pubitemid 36444329)
12. Lansbury P T and Lashuel H A 2006 A century-old debate on protein aggregation and neurodegeneration enters the clinic Nature 443 774-9 (Pubitemid 44622681)
13. Walsh D M and Selkoe D J 2004 Oligomers in the brain: the emerging role of soluble protein aggregates in neurodegeneration Protein Peptide Lett. 11 213-28 (Pubitemid 38689025)
14. Oosawa F and Asakura S 1975 Thermodynamics of the Polymerization of Protein (New York: Academic Press)
15. Ferrone F 2006 Nucleation: the connections between equilibrium and kinetic behavior Method. Enzymol. 412 285-99 (Pubitemid 44548586)
16. Padrick S B and Miranker A D 2002 Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis Biochemistry 41 4694-703 (Pubitemid 34275671)
17. Wetzel R 2006 Kinetics and thermodynamics of amyloid fibril assembly Acc. Chem. Res. 39 671-9
18. Cannon M J, Williams A D, Wetzel R and Myszka D G 2004 Kinetic analysis of beta-amyloid fibril elongation Anal. Biochem. 328 67-75 (Pubitemid 38479619)
19. Snow A D and Wight T N 1989 Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidosis Neurobiol. Aging 10 481-97 (Pubitemid 19245453)
20. Inoue S 2001 Basement membrane and β amyloid fibrillogenesis in Alzheimer's disease Int. Rev. Cytol. 210 121-61 (Pubitemid 32888802)
21. Ancsin J B 2003 Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit Amyloid: J. Protein Folding Disord 10 67-79 (Pubitemid 36936537)
22. Knight J D and Miranker A D 2004 Phospholipid catalysis of diabetic amyloid assembly J. Mol. Biol 341 1175-87 (Pubitemid 39099208)
23. Lashuel H A and Lansbury P T Jr 2006 Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Quart. Rev. Biophys 39 167-201
24. Quist A, Doudevski I, Lin H, Azimova R, Ng D, Frangione B, Kagan B, Ghiso J and Lal R 2005 Amyloid ion channels: a common structural link for protein-misfolding disease Proc. Natl. Acad. Sci. USA 102 10427-32 (Pubitemid 41061570)
25. Munishkina L A and Fink A L 2007 Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins BBCA Biomembr. 1768 1862-85 (Pubitemid 47125851)
26. Kirkitadze M D, Condron M M and Teplow D B 2001 Identification and characterization of key kinetic intermediates in amyloid b-protein fibrillogenesis J. Mol. Biol. 312 1103-19 (Pubitemid 32980329)
27. Teplow D B et al 2006 Elucidating amyloid β-protein folding and assembly: a multidisciplinary approach Acc. Chem. Res. 39 635-45
28. Fezoui Y, Hartley D M, Walsh D M, Selkoe D, Osterhout J J and Teplow D B 2000 A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils Nat. Struct. Biol. 7 1095-9
29. Mihara H and Takahashi Y 1997 Engineering peptides and proteins that undergo α to b transition Curr. Opin. Struct. Biol. 7 501-8 (Pubitemid 27371294)
30. van Beek J D, Beaulieu L, Schafer H, Demura M, Aaskura T and Meier B H 2000 Solid state NMR determination of the secondary structure of Samia Cynthia silk Nature 405 1077-9 (Pubitemid 30447795)
31. Goldsbury C, Goldie K, Pellaud J, Seelig J, Frey P, Muller S A, Kistler J, Cooper G J S and Aebi U 2000 Amyloid fibril formation from full-length and fragments of amylin J. Struct. Biol. 130 352-362
32. Williamson J and Miranker A 2007 Direct detection of transient α-helical states in islet amyloid polypeptide Protein Sci 16 110-17 (Pubitemid 46036503)
33. Breeze A L, Harvey T S, Bazzo R and Campbell I D 1991 Solution structure of human calcitonin gene-related peptide by 1 H-NMR and distance geometry with restrained molecular dynamics Biochemistry 30 575-82
34. Kunjithapatham R, Oliva F Y, Doshi U, Pérez M, vila J and Munoz V 2005 Role for the α-helix in aberrant protein aggregation Biochemistry 44 149-56 (Pubitemid 40095716)
35. Jayasinghe S A and Langen R 2005 Lipid membranes modulate the structure of islet amyloid polypeptide Biochemistry 44 12113-9 (Pubitemid 41285709)
36. Knight J D, Hebda J A and Miranker A D 2006 Conserved and cooperative assembly of membrane bound α-helical states of islet amyloid polypeptide Biochemistry 45 9496-508 (Pubitemid 44223253)
37. Jayasinghe S A and Langen R 2007 Membrane interaction of islet amyloid polypeptide BBCA Biomembr. 1768 2002-9 (Pubitemid 47125849)
38. Apostolidou M, Jayasinghe S A and Langen R 2008 Structure of α-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding J. Biol. Chem 283 17205-10
39. Olofsson A, Borowik T, Grobner G and Sauer-Eriksson A E 2007 Negatively charged phospholipids membranes induce amyloid formation of Medin via an α-helical intermediate J. Mol. Biol. 374 186194 (Pubitemid 47600226)
40. Perrin R J, Woods W S, Clayton D F and George J M 2000 Interaction of human α-Synuclein and Parkinson's diseases variants with phospholipids J. Biol. Chem 275 34393-8
41. Eliezer D, Kutluay E, Bussell R Jr and Brown G 2001 Conformational properties of alpha-synuclein in its free and lipid associated states J. Mol. Biol. 307 799-807 (Pubitemid 33029953)
42. Zhu M, Li J and Fink A L 2003 Lipid binding inhibits α-Synuclein fibril formation J. Biol. Chem. 278 16873-7 (Pubitemid 36799558)
43. Lee H J, Choi C and Lee S J 2002 Membrane bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form J. Biol. Chem. 277 671-8
44. Meng F, Abedini A and Raleigh D P 2007 Amyloid formation by pro-islet amyloid polypeptide processing intermediates: examination of the role of protein heparan sulfate interactions and implications for islet amyloid formation in type 2 diabetes Biochemistry 46 12091-9 (Pubitemid 350022365)
45. Knight J D and Miranker A D 2004 Phospholipid catalysis of diabetic amyloid assembly J. Mol. Biol. 341 1175-87 (Pubitemid 39099208)
46. Nilsson M R and Raleigh D P 1999 Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin J. Mol. Biol. 294 1375-85 (Pubitemid 30008807)
47. Park K and Verchere C B 2001 Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide J. Biol. Chem 276 16611-6
48. Abedini A, Tracz S M, Cho J and Raleigh D 2006 Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation Biochemistry 45 9228-37 (Pubitemid 44156386)
49. Zanni M T and Hochstrasser R M 2001 Two-dimensional infrared spectroscopy: a promising new method for the time resolution of structures Curr. Opin. Struct. Bio. 11 516-22 (Pubitemid 32972011)
50. Mukherjee P, Kass I, Arkin I and Zanni M T 2006 Picosecond dynamics of a membrane protein revealed by 2D IR Proc. Natl. Acad. Sci. USA 103 3528-33 (Pubitemid 43376589)
51. Shim S-H, Strasfeld D B, Ling Y L and Zanni M T 2007 Automated 2D IR spectroscopy using a mid-IR pulse shaper and application of this technology to the human islet amyloid polypeptide Proc. Natl. Acad. Sci. USA 104 14197-202 (Pubitemid 350003240)
52. Kim Y S, Liu L, Axelsen P H and Hochstrasser R M 2008 Two-dimensional infrared spectra of isotopically diluted amyloid fibrils from Aβ40 Proc. Natl. Acad. Sci. 105 7720-5
53. Abedini A, Meng F and Raleigh D A 2007 Single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor J. Am. Chem. Soc. 129 11300-1 (Pubitemid 47555526)